24 HR dapagliflozin 10 MG / Metformin hydrochloride 1000 MG Extended Release Oral Tablet

Known as: dapagliflozin 10 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet, DAPAGLIFLOZIN 10MG/METFORMIN 1000MG 24HR TAB,SA, dapagliflozin 10 MG / Metformin hydrochloride 1000 MG 24 HR Extended Release Oral Tablet 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2016
01220102016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
It is unclear whether the improvement in diabetic nephropathy by sodium glucose cotransporter 2 (SGLT2) inhibitors is caused by a… (More)
  • table 1
  • table 2
  • table 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Der vorliegende Supplement-Band der Deutschen Medizinischen Wochenschrift fasst drei wichtige klinische Studien zur Wirksamkeit… (More)
Is this relevant?
2012
2012
Human Na(+)-D-glucose cotransporter (hSGLT) inhibitors constitute the newest class of diabetes drugs, blocking up to 50% of renal… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2012
Review
2012
Dapagliflozin (Forxiga®) is the first in a novel class of glucose-lowering agents known as sodium-glucose co-transporter-2 (SGLT2… (More)
  • figure 1
  • table I
  • table II
  • table III
  • figure 2
Is this relevant?
Review
2010
Review
2010
  • Drugs in R&D
  • 2010
Dapagliflozin, a selective inhibitor of the sodium glucose co-transporter type 2 (SGLT2) is in development for type 2 diabetes… (More)
  • table I
  • table II
  • table III
Is this relevant?